Assignee
Neurovision Pharma GmbH
DE·2 granted patents·2 pending applications·3 citations·filing 2015–2021
Top patents by PatentIndex Score
4 records- 0176US11213541B2Antisense-oligonucleotides as inhibitors of TGF-R signalingNeurovision Pharma GmbH·Filed 2015·Granted Jan 4, 2022·2 cites·5 claims
- 0265US2022143071A1Antisense-oligonucleotides as inhibitors of tgf-r signalingNeurovision Pharma GmbH·Filed 2021·Application pending·0 cites
- 0363US10363266B2Antisense-oligonucleotides as inhibitors of TGF-R signalingNeurovision Pharma GmbH·Filed 2015·Granted Jul 30, 2019·1 cites·5 claims
- 0454US2019314401A1Antisense-oligonucleotides as inhibitors of tgf-r signalingNeurovision Pharma GmbH·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Neurovision Pharma GmbH files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →